Prafull Mistry

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome

Xavier Mariette, Francesca Barone, Chiara Baldini et al. · JCI Insight · 2022 · 130 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease

Sofia Tzimopoulou, Vincent J. Cunningham, Thomas E. Nichols et al. · Journal of Alzheimer s Disease · 2011 · 109 citations

Life Sciences, Neurology, Neuroscience +5

Long‐Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus

Richard Furie, Daniel J. Wallace, Cynthia Aranow et al. · Arthritis & Rheumatology · 2018 · 96 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus

Elizabeth McKie, Juliet Reid, Prafull Mistry et al. · PLoS ONE · 2016 · 80 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects

Prafull Mistry, Juliet Reid, Isabelle Pouliquen et al. · International Journal of Clinical Pharmacology and Therapeutics · 2014 · 41 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +10